Adjuik, M; Agnamey, P; Babiker, A; Borrmann, S; Brasseur, P; Cisse, M; Cobelens, F; Diallo, S; Faucher, JF; Garner, P; Gikunda, S; Kremsner, PG; Krishna, S; Lell, B; Loolpapit, M; Matsiegui, PB; Missinou, MA; Mwanza, J; Ntoumi, F; Olliaro, P; Osimbo, P; Rezbach, P; Some, Eliab; Taylor, WR
(The Lancet, 2002)
Background: Increasing drug resistance limits the choice of efficacious chemotherapy against Plasmodium falciparum malaria in Africa. Amodiaquine still retains efficacy against P falciparum in many African countries. We ...